Insider Buying: Cosmos Health (NASDAQ:COSM) CEO Purchases 168,472 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 168,472 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was acquired at an average price of $0.42 per share, with a total value of $70,758.24. Following the acquisition, the chief executive officer owned 6,628,457 shares in the company, valued at $2,783,951.94. The trade was a 2.61% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas purchased 55,732 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas acquired 56,080 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.68 per share, for a total transaction of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The shares were bought at an average cost of $0.62 per share, with a total value of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas bought 61,614 shares of Cosmos Health stock. The shares were bought at an average cost of $0.65 per share, for a total transaction of $40,049.10.

Cosmos Health Trading Up 15.3%

Shares of COSM traded up $0.06 during mid-day trading on Tuesday, reaching $0.48. 834,726 shares of the company were exchanged, compared to its average volume of 619,247. The business has a 50 day simple moving average of $0.77 and a two-hundred day simple moving average of $0.72. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.84 and a current ratio of 0.99. The stock has a market capitalization of $16.73 million, a PE ratio of -0.64 and a beta of 5.34. Cosmos Health Inc. has a 52 week low of $0.28 and a 52 week high of $1.32.

Cosmos Health (NASDAQ:COSM) last released its earnings results on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). The firm had revenue of $17.11 million for the quarter, compared to analyst estimates of $16.40 million. Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. On average, analysts predict that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on COSM shares. Wall Street Zen upgraded shares of Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC raised its stake in shares of Cosmos Health Inc. (NASDAQ:COSM) by 133.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 225,507 shares of the company’s stock after acquiring an additional 128,776 shares during the period. Citadel Advisors LLC owned about 0.65% of Cosmos Health worth $250,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.